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Some data were presented incorrectly in the published version of [Table 1](#t1-vhrm-8-443){ref-type="table"}. The correct [Table 1](#t1-vhrm-8-443){ref-type="table"} is as follows:

###### 

Comparison of the eight currently available angiotensin-receptor blockers

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Generic name   Brand name                                        Dose (mg)   Cost (28-tab pack)   Metabolism                                                                                    Half-life (hours)   Primary function                                     Dosing                                                                                                                                                                                                                                    AT~1~/AT~2~ receptor selectivity   Pressor inhibition at 24 hours
  -------------- ------------------------------------------------- ----------- -------------------- --------------------------------------------------------------------------------------------- ------------------- ---------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------- --------------------------------
  Azilsartan     Edarbi (Takeda)                                   40          £16.80               Hepatic: Mainly CYP2C9 (also CYP2B6 and CYP2C8); no CYP inhibition; inhibits p-glycoprotein   11                  Hypertension                                         40--80 mg once daily for hypertension                                                                                                                                                                                                     \>10,000-fold                      32 mg 60%

                                                                   80          £19.95                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Candesartan    Atacand                                           4           £9.78                Ester hydrolysis within gastrointestinal wall                                                 9                   Hypertension, heart failure                          8--32 mg once daily over 4-(for hypertension) or 2-(for heart failure) week intervals                                                                                                                                                     \>10,000-fold                      8 mg 50%

                                                                   32          £16.13                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Eprosartan     Teveten                                           300         £7.31                Not metabolized and eliminated unchanged                                                      20                  Hypertension                                         400--800 mg once daily, increase after 2--3 weeks                                                                                                                                                                                         1000-fold                          350 mg 30%

                                                                   600         £14.31                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Irbesartan     Aprovel (Bristol-Myers Squibb) (Sanofi-Aventis)   75          £9.69                Hepatic: glucuronidation and oxidation by CYP2C9                                              11--15              Hypertension, diabetic nephropathy                   150--300 mg once daily for hypertension and renal disease in hypertensive type 2 diabetes mellitus                                                                                                                                        \>8500-fold                        150 mg 40%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        300 mg 60%

                                                                   300         £15.93                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Losartan       Losartan Potassium, Cozaar                        25          £1.45 £16.18         Hepatic: CYP2C9 and CYP3A4                                                                    2                   Hypertension, diabetic nephropathy                   25--100 mg once daily over several weeks for hypertension and diabetic nephropathy; 12.5--150 mg once daily over weekly intervals for chronic heart failure                                                                               1000-fold                          100 mg 25%--40%

                                                                   100         £1.47\                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                               £16.18                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Olmesartan     Olmetec                                           20          £12.95               Ester hydrolysis within gastrointestinal wall                                                 13                  Hypertension                                         10--40 mg once daily for hypertension                                                                                                                                                                                                     \>12,500-fold                      20 mg 61%\
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        40 mg 74%

                                                                   40          £17.50                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Telmisartan    Micardis (Boehringer Ingelheim)                   40          £8.00                Minimally conjugated, no CYP450 activation                                                    24                  Hypertension                                         40--80 mg once daily after 4 weeks for hypertension; 80 mg once daily to prevent cardiovascular events                                                                                                                                    \>3000-fold                        80 mg 40%

                                                                   80          £17.00                                                                                                                                                                                                                                                                                                                                                                                                                                                                   

  Valsartan      Diovan (Novartis)                                 40\         £13.97\              Minimal metabolism (CYP2C9) and eliminated largely unchanged                                  6                   Hypertension, heart failure, myocardial infacrtion   80--320 mg once daily over 4 weeks for hypertension; 40 mg twice daily, up to 160 mg twice daily, over 2-week intervals for heart failure; 20 mg twice daily, up to 160 mg twice daily, over 2-week intervals for myocardial infarction   20,000-fold                        80 mg 30%
                                                                   160         £18.41                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:** Data drawn from Zaiken K, Cheng JW. Azilsartan medoxomil: a new angiotensin receptor blocker. *Clin Ther*. 2011;33(11):1577--1589.^23^
